COMMUNIQUÉS West-GlobeNewswire

-
VitalHub UK Expands Healthtech Portfolio into Middle East through a Partnership with ADHDS
20/02/2024 -
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum
20/02/2024 -
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
20/02/2024 -
Clearmind Medicine Submits Three International Patent Applications for Next Generation Classic Psychedelic-Based Compounds
20/02/2024 -
SciSparc and Clearmind Continue to Strengthen International Patent Portfolio with Next Generation Classic Psychedelic-Based Compounds
20/02/2024 -
Emerging Markets Report: Look Who’s Talking
20/02/2024 -
Celcuity Appoints Eldon Mayer as Chief Commercial Officer
20/02/2024 -
Kraig Biocraft Laboratories Announces New Premium Spider Silk and Pima Cotton Composite Yarn
20/02/2024 -
Fortrea to Present at the Barclays 26th Annual Global Healthcare Conference
20/02/2024 -
Arvinas Announces First-in-Human Dosing of ARV-102, an Investigational PROTAC® Protein Degrader for Neurodegenerative Disease
20/02/2024 -
Apellis Pharmaceuticals to Host Conference Call on February 27, 2024, to Discuss Fourth Quarter and Full Year 2023 Financial Results
20/02/2024 -
Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
20/02/2024 -
Voyager Therapeutics Reports Robust Preclinical Activity in Tau Silencing Gene Therapy Program for Alzheimer’s Disease and Advances Program into Late Research
20/02/2024 -
FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results
20/02/2024 -
SweetWater Brewing Teams Up With Major League Soccer’s Atlanta United FC as Official Craft Beer Partner
20/02/2024 -
Acquisition of Freeline by Syncona Becomes Effective
20/02/2024 -
Axsome Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
20/02/2024 -
ANI Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference
20/02/2024 -
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
20/02/2024
Pages